In B16-F10 (melanoma), LLC1 (Lewis lung carcinoma), MB49 (bladder carcinoma), KPC (pancreatic ductal adenocarcinoma), and 4T1 (mammary carcinoma) cells, caspase-2 was expressed at much lower levels (Fig. 5C). Here, CASP2 is linked to breast carcinoma.